{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:28:25Z","timestamp":1773628105493,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.109","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:28:27Z","timestamp":1233480507000},"page":"1912-1922","source":"Crossref","is-referenced-by-count":34,"title":["Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles"],"prefix":"10.1016","volume":"27","author":[{"given":"Vanessa","family":"Durand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Circe","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Quesniaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Le Bon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Y.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.01.109_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1286-4579(00)00356-7","article-title":"Epidemiology and pathogenesis of Neisseria meningitidis","volume":"2","author":"Tzeng","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2009.01.109_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"26","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.109_bib3","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.109_bib4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0264-410X(97)00030-3","article-title":"Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response","volume":"15","author":"Andersen","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.109_bib5","first-page":"67","article-title":"Production, characterization and control of MenB-vaccine \u201cFolkehelsa\u201d: an outer membrane vesicle vaccine against group B meningococcal disease","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2009.01.109_bib6","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","article-title":"Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease","volume":"21","author":"Aase","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.109_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.70.2.702-707.2002","article-title":"Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine","volume":"70","author":"Katial","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.109_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(00)00333-9","article-title":"Development of natural immunity to Neisseria meningitidis","volume":"19","author":"Pollard","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.109_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/IAI.70.3.1301-1309.2002","article-title":"Characterization of humoral and cellular immune responses elicited by meningococcal carriage","volume":"70","author":"Robinson","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib11","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.109_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/IAI.67.2.921-927.1999","article-title":"Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine","volume":"67","author":"Oftung","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib14","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.4049\/jimmunol.171.8.4263","article-title":"Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis","volume":"171","author":"Davenport","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1462-5822.2006.00851.x","article-title":"Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa","volume":"9","author":"Davenport","year":"2007","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib16","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/IAI.72.5.2528-2537.2004","article-title":"Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis","volume":"72","author":"Guthrie","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","article-title":"Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice","volume":"67","author":"Saunders","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0264-410X(99)00216-9","article-title":"Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers","volume":"18","author":"Drabick","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.109_bib19","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.4049\/jimmunol.172.7.4425","article-title":"Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans","volume":"172","author":"Quesniaux","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/mpat.1995.0054","article-title":"Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines","volume":"19","author":"Andersen","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2009.01.109_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/33046","article-title":"Meningitis bacterium is viable without endotoxin","volume":"392","author":"Steeghs","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.109_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/IAI.70.3.1293-1300.2002","article-title":"Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis","volume":"70","author":"Andersen","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib23","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1093\/emboj\/20.24.6937","article-title":"Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant","volume":"20","author":"Steeghs","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2009.01.109_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.0818-9641.2004.01285.x","article-title":"Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha\/beta","volume":"82","author":"Durand","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2009.01.109_bib26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.109_bib27","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation","volume":"99","author":"Montoya","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2009.01.109_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1074-7613(00)80340-4","article-title":"Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology","volume":"6","author":"Aichele","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2009.01.109_bib29","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.161.10.5338","article-title":"Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division","volume":"161","author":"Oehen","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Le Bon","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/159.2.195","article-title":"Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease","volume":"159","author":"Brandtzaeg","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.109_bib32","first-page":"401","article-title":"Neisseria meningitidis lipopolysaccharides in human pathology","volume":"7","author":"Brandtzaeg","year":"2001","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2009.01.109_bib33","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1073\/pnas.89.10.4633","article-title":"A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes","volume":"89","author":"Liu","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2009.01.109_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1084\/jem.168.1.107","volume":"168","author":"Mandrell","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.109_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.vaccine.2009.01.109_bib36","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.4049\/jimmunol.145.9.3071","article-title":"Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine","volume":"145","author":"Donnelly","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.183.3.1151","article-title":"Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate","volume":"183","author":"Wetzler","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.109_bib38","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4049\/jimmunol.168.4.1533","article-title":"Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent","volume":"168","author":"Massari","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib39","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.174.6.3545","article-title":"Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent","volume":"174","author":"Singleton","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O\u2019Neill","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: from basic science to medicine-40 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/342478a0","article-title":"Immunology. Stimulating killer cells","volume":"342","author":"Bevan","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.109_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/18038","article-title":"Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen","volume":"398","author":"Sigal","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.109_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-presentation, dendritic cells, tolerance and immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/eji.200323919","article-title":"Role of Toll-like receptors in costimulating cytotoxic T cell responses","volume":"33","author":"Schwarz","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.20031591","article-title":"Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN","volume":"199","author":"Ahonen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.01.109_bib48","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.vaccine.2005.08.111","article-title":"Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens","volume":"24","author":"Mesa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.109_bib49","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.139.6.1991","article-title":"Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon","volume":"139","author":"Gessani","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib50","doi-asserted-by":"crossref","first-page":"38383","DOI":"10.1074\/jbc.M508063200","article-title":"Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B","volume":"280","author":"Post","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.01.109_bib51","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.171.6.3119","article-title":"Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology","volume":"171","author":"Higgins","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib52","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood-2005-10-4190","article-title":"Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response","volume":"107","author":"Fujita","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2009.01.109_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2009.01.109_bib54","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular basis of bacterial outer membrane permeability revisited","volume":"67","author":"Nikaido","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2009.01.109_bib56","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/eji.200535493","article-title":"Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge","volume":"36","author":"Etchart","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.109_bib57","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/IAI.73.7.4070-4080.2005","article-title":"Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination","volume":"73","author":"Fisseha","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.109_bib58","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1128\/IAI.00005-08","article-title":"Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis","volume":"76","author":"Steeghs","year":"2008","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:56:25Z","timestamp":1684875385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":58,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001728"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.109","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}